A little DD: NDA is April 22, 2014 PDUFA is May 25th 2014 http://www.biopharmcatalyst.com/fda-calendar/ The company has 17 million in cash. See page 3: http://www.otcmarkets.com/financialReportViewer?symbol=QRXPY&id=116633 Even Better From Page 3 Both Aspen and Teva will assume responsibility for all regulatory and product launch costs as well as ongoing marketing and sales efforts with respect to the above strategic collaborations. Full writeup on Seeking Alpha http://seekingalpha.com/article/2102433-qrxpharma-pivotal-catalysts-present-significant-near-term-upside-potential I took a starter position today.